Item 2.02 Results of Operations and Financial Condition.

On May 14, 2020, BioLife Solutions, Inc. (the "Company") issued a press release announcing the preliminary financial results and operational highlights for the first quarter ended March 31, 2020. A copy of the press release is furnished as Exhibit 99.1 to this current report on Form 8-K.




Item 8.01   Other Events.

On May 14, 2020, the Company also announced that it entered into a share purchase agreement with Casdin Capital LLC, a New York-based, life science-focused investment firm and current stockholder of the Company ("Casdin"), pursuant to which Casdin agreed to invest $20 million in the Company at a price per share of $10.50.

Additionally, on May 14, 2020, the Company entered into separate warrant exercise agreements with WAVI Holding AG and Taurus4757 GmbH pursuant to which the warrant holders immediately exercised their respective warrants via a "cashless" exercise as agreed to by the Company. As a result of the cashless exercise, the Company issued approximately 2.7 million shares to the warrant holders and has eliminated approximately 3.9 million warrants from its overhang.




Item 9.01   Financial Statements and Exhibits.



(d) Exhibits



Exhibit No.   Description
99.1            Press release, dated May 14, 2020

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses